GL
Georgetown Lombardi Comprehensive Cancer Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Georgetown Lombardi Comprehensive Cancer Center takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer, especially targeted treatment of EGFR-mutant non-small cell lung cancer. It also covers shifting approaches in extensive-stage small cell lung cancer and the next wave of antibody-drug conjugates for lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
GL Georgetown Lombardi Comprehensive Cancer Center Washington, DC | |
US National Cancer Institute-designated comprehensive cancer centre of Georgetown University in Washington, DC. | Abstract Sat Oct 24 17:30–17:42 Invited Discussant LBA3 Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers Satellite Sun Oct 25 13:05–13:15 EGFR: Paradigm of targeted therapy Lung & thoracic cancers Satellite Sun Oct 25 13:52–14:07 Beyond efficacy: Optimizing approaches in EGFR-mutant NSCLC Lung & thoracic cancers Satellite Mon Oct 26 13:00–14:30 F. Hoffmann - La Roche LTD - Advancing the Frontiers of Lung Cancer Care Lung & thoracic cancers Satellite Mon Oct 26 13:00–13:05 Welcome and Introduction: the Evolving Map of Lung Cancer Lung & thoracic cancers Satellite Mon Oct 26 13:50–14:15 Shifting Paradigms in ES-SCLC and the Next Wave of ADCs in Lung Cancer Lung & thoracic cancers |
Instantly find 20 buyers from Georgetown Lombardi Comprehensive Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction